St. Alphonsus Health System
Print    Email
Decrease (-) Restore Default Increase (+)

Other Research Opportunities at Saint Alphonsus

Title   Use of IV Hydralazine and Labetolol for the Treatment of Hypertension in the Inpatient Setting
Description   Retrospective, data collection study to determine if there are significant differences between patients that received IV hydralazine or labetolol with appropriate indications versus those without appropriate indications.
IRB Number   12-14
Treatment   Med Safety
Principal Name   Kathy Eroschenko, PharmD and J. Antonio G. Lopez, MD
Current Trial Type   Retrospective, data collection
Phone   (208) 373-1837



Saint Alphonsus Health System  |  1055 North Curtis Road  Boise, ID 83706  |  208-367-2121

   Facebook       Twitter       YouTube